Chennai Meenakshi Multispeciality Hospital Ltd vs Dhanvantri Jeevan Rekha Ltd Stock Comparison
Chennai Meenakshi Multispeciality Hospital Ltd vs Dhanvantri Jeevan Rekha Ltd Stock Comparison
Last Updated on: Oct 25, 2026
Key Highlights
The Latest Trading Price of Chennai Meenakshi Multispeciality Hospital Ltd is ₹ 36.4 as of 23 Oct 15:30
. The P/E Ratio of Chennai Meenakshi Multispeciality Hospital Ltd changed from 4.3 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Dhanvantri Jeevan Rekha Ltd changed from 14.1 on March 2022 to 26.7 on March 2026 . This represents a CAGR of 13.62% over 5 years The Market Cap of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ 7.28 crore on March 2021 to ₹ 24.66 crore on March 2026 . This represents a CAGR of 22.55% over 6 yearsThe Market Cap of Dhanvantri Jeevan Rekha Ltd changed from ₹ 3.06 crore on March 2021 to ₹ 10.3 crore on March 2026 . This represents a CAGR of 22.42% over 6 years The revenue of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 8.7 crore as compare to the Mar '26 revenue of ₹ 10.05 crore. This represent the decline of -13.43% The revenue of Dhanvantri Jeevan Rekha Ltd for the Jun '26 is ₹ 7.87 crore as compare to the Mar '26 revenue of ₹ 7.34 crore. This represent the growth of 7.22% The ebitda of Chennai Meenakshi Multispeciality Hospital Ltd for the Jun '26 is ₹ 0.46 crore as compare to the Mar '26 ebitda of ₹ 0.48 crore. This represent the decline of -4.17% The ebitda of Dhanvantri Jeevan Rekha Ltd for the Jun '26 is ₹ 0.36 crore as compare to the Mar '26 ebitda of ₹ 0.49 crore. This represent the decline of -26.53% The net profit of Chennai Meenakshi Multispeciality Hospital Ltd changed from ₹ -0.38 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00%
The net profit of Dhanvantri Jeevan Rekha Ltd changed from ₹ 0.16 crore to ₹ 0.18 crore over 9 quarters. This represents a CAGR of 5.37%
The Dividend Payout of Chennai Meenakshi Multispeciality Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Dhanvantri Jeevan Rekha Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .
About Chennai Meenakshi Multispeciality Hospital Ltd
Chennai Meenakshi Multispeciality Hospital Limited, formerly known as Devaki Hospital Limited, was incorporated in 1990.
The Company name was changed from Devaki Hospital Limited to Chennai Meenakshi Multispeciality Hospital Limited in October, 2007.
It is a 100-bedded hospital located in the heart of Chennai at Mylapore.
The hospital has an infrastructure comprising of around 105 Beds including ICU Beds, Operating Theatre, a modern dialysis Unit besides a host of other facilities.
The Company has a pool of talented and experienced doctors who are further supported by a team of highly qualified and experienced and dedicated support staff and cutting edge technology.
The Company operate into various departments like Cardiology Department; Casualty Department; Diagnostic Services; Intensive Care Unit; Nephrology Department and Physiotherapy Department.
About Dhanvantri Jeevan Rekha Ltd
Dhanvantri Jeevan Rekha Limited, incorporated on June 11, 1993 is a multi speciality hospital providing reliable diagnostic and therapeutical services.
Dhanvantri Hospital with advance and high-class patient care, made humble beginning around 30 years ago in 1993 at 1- Saket, Meerut.
The Hospital has grown in becoming a major healthcare provider to all walks of life in Meerut and the surrounding region.
The Company was incorporated as a Public Limited Company with the Registrar of Companies in Uttar Pradesh with the main object of providing diagnostic and therapeutic services including Magnetic Resonance Imaging (MRI).
It obtained Certificate for Commencement of Business on August 2, 1993.
In October 1993, the Company acquired a constructed building at Saket, in Meerut for establishing the Diagnostic Centre.
FAQs for the comparison of Chennai Meenakshi Multispeciality Hospital Ltd and Dhanvantri Jeevan Rekha Ltd
Which company has a larger market capitalization, Chennai Meenakshi Multispeciality Hospital Ltd or Dhanvantri Jeevan Rekha Ltd?
Market cap of Chennai Meenakshi Multispeciality Hospital Ltd is 27 Cr while Market cap of Dhanvantri Jeevan Rekha Ltd is 9 Cr
What are the key factors driving the stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Dhanvantri Jeevan Rekha Ltd?
The stock performance of Chennai Meenakshi Multispeciality Hospital Ltd and Dhanvantri Jeevan Rekha Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Chennai Meenakshi Multispeciality Hospital Ltd and Dhanvantri Jeevan Rekha Ltd?
As of October 25, 2026, the Chennai Meenakshi Multispeciality Hospital Ltd stock price is INR ₹36.4. On the other hand, Dhanvantri Jeevan Rekha Ltd stock price is INR ₹23.56.
How do dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Dhanvantri Jeevan Rekha Ltd compare?
To compare the dividend payouts of Chennai Meenakshi Multispeciality Hospital Ltd and Dhanvantri Jeevan Rekha Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.